---
quick_id: 260527-3eb
slug: update-stage15-10-seed-trace-biopt-evide
status: complete
completed_at: 2026-05-27T02:26:47+08:00
---

# Quick Task 260527-3eb Summary

Updated TRACE-BiOpt evidence documentation after completing `stage15_biopt_allbudget_10seed_v2`.

## Completed

- Recorded ten-seed Stage15 dominance evidence in `TRACE_BIOPT_SPEC.md` and `TRACE_BIOPT_THEORY.md`.
- Updated `.planning/PROJECT.md` and `.planning/STATE.md` to make the ten-seed artifact the current primary claim basis.
- Preserved the caveat that PeMS7_1026 at 30% budget is directional mean-dominance evidence, not final significance wording.

## Verification

- `python -m py_compile TRC-23-02333/transparent_estimator_eval.py TRC-23-02333/trace_biopt.py TRC-23-02333/summarize_trace_sl_rcss.py scripts/generate_trace_biopt_dominance.py scripts/generate_trace_biopt_claim_contract.py`
- `pytest -q TRC-23-02333/test_transparent_estimator_eval.py TRC-23-02333/test_summarize_trace_sl_rcss.py scripts/test_generate_trace_biopt_dominance.py scripts/test_generate_trace_biopt_claim_contract.py tests/test_stage12_runtime_fast_paths.py tests/test_stage12_runtime_trace_cache.py`
- `bash -n scripts/run_stage15_biopt_weak_points.sh`
- Checked `stage15_biopt_allbudget_10seed_v2/combined/trace_biopt_claim_contract.json`: schema `trace_biopt_claim_contract_v1`, 9 rows, aggregate status `supported_directional`, 5 submission-ready rows, weakest row PeMS7_1026 30%.
